Clinical Trials Browser

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT07273656 2025-12-09

TIRBACRYO

Phase 3 Not yet recruiting

59 enrolled

Dermatologic

Keratosis, Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Phase 4 Completed

334 enrolled 12 charts

Dermatologic

Keratosis, Keratosis, Actinic

NCT05060237 2024-10-17

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Phase 1 Completed

112 enrolled 21 charts

DermatologicOther neoplasm

Keratosis, Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT05942794 2024-02-28

Identification of Oral Lesions Through an Autofluorescence System

Phase NA Unknown

200 enrolled

DermatologicHead & Neck

Carcinoma, Squamous Cell, Keratosis, Leukoplakia, Oral, Lichen Planus, Mouth Diseases, Mouth Neoplasms, Lichen Planus, Oral

NCT03285477 2021-04-13

AK003

Phase 3 Completed

351 enrolled 17 charts

DermatologicOther neoplasm

Keratosis, Neoplasms, Precancerous Conditions, Skin Diseases, Keratosis, Actinic

NCT00535080 2021-02-18

Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease

No longer available

Dermatologic

Bowen's Disease, Carcinoma, Carcinoma, Basal Cell, Keratosis

NCT02851693 2019-04-04

OCTSKIN

Phase NA Withdrawn

Dermatologic

Carcinoma, Keratosis, Mixed Tumor, Malignant

NCT02737176 2016-08-01

TISOD

Phase NA Unknown

812 enrolled

DermatologicHead & Neck

Keratosis, Leukoplakia, Lichen Planus, Mouth Diseases, Periodontal Diseases, Smoking Cessation

NCT00121511 2015-05-27

The Effect of Efudex Treatment on Photoaged Skin

Phase NA Completed

21 enrolled

Dermatologic

Keratosis, Keratosis, Actinic

NCT00239135 2015-03-25

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Phase 2 Completed

34 enrolled

Dermatologic

Keratosis, Melanosis, Keratosis, Actinic

NCT01229319 2011-06-22

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

Phase 4 Unknown

20 enrolled

Dermatologic

Keratosis, Keratosis, Actinic

NCT00110682 2008-04-24

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses

Phase 4 Completed

60 enrolled

Dermatologic

Keratosis, Keratosis, Actinic

NCT00114023 2007-02-19

1-Year Follow up to the 1473-IMIQ Study

Completed

84 enrolled

Dermatologic

Keratosis, Keratosis, Actinic

NCT00115154 2007-02-19

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Phase 4 Completed

270 enrolled

Dermatologic

Keratosis, Keratosis, Actinic

Clinical Trials

TirbAKare

TIRBACRYO

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Identification of Oral Lesions Through an Autofluorescence System

AK003

Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease

OCTSKIN

TISOD

The Effect of Efudex Treatment on Photoaged Skin

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses

1-Year Follow up to the 1473-IMIQ Study

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands